Healthcare Global Enterprises Ltd. (HCG)
NSE
712.55
+21.95 (+3.18%)
Closed
Sep 9, 2026
Day's Range
688.00715.65
52 wk Range
513.30804.65
Financial Statements - HCG - Healthcare Global Enterprises Ltd.
Revenue
25.38B▲ 15.3%
Net Income
227.80M▼ 53.4%Net Margin 0.9%
EBITDA
4.85B▲ 15.1%
Free Cash Flow
550.00M▼ 49.2%
Income Statement
| Period Ending | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 | 2021-03-31 |
|---|---|---|---|---|---|---|
| Sales | 25.38B | 22B | 18.89B | 16.76B | 13.83B | 10.04B |
| Cost of Goods | 12.41B | 10.83B | 9.09B | 7.99B | 6.82B | 4.99B |
| Gross Profit | 12.97B | 11.17B | 9.79B | 8.76B | 7.01B | 5.04B |
 Operating Expense | - | - | - | - | - | - |
| Operating Income | 2.21B | 1.86B | 1.56B | 1.65B | 774.45M | -325.85M |
| Non-Operating Interest | - | - | - | - | - | - |
| Other Income Expense | - | - | - | - | - | - |
| Pre Tax Income | 269.20M | 569.64M | 677.29M | 448.80M | 877.72M | -2.28B |
| Income Tax | 41.40M | 81.30M | 263.95M | 272.50M | 488.47M | -75.61M |
| Net Income | 227.80M | 488.34M | 413.34M | 176.30M | 389.25M | -2.21B |
| EPS Basic | 0.97 | 3.170404 | 3.46 | 2.11 | 4.14 | -17.02 |
| EPS Diluted | 0.96 | 3.120712 | 3.43 | 2.1 | 3.97 | -17.02 |
| Basic Shares Outstanding | 141.85M | 140.24M | 139.23M | 139.07M | 129.70M | 113.64M |
| Diluted Shares Outstanding | 141.85M | 140.24M | 139.23M | 139.07M | 129.70M | 113.64M |
| Ebit | 2.03B | 2.03B | 1.67B | 1.36B | 1.71B | -1.18B |
| Ebitda | 4.85B | 4.21B | 3.37B | 3.32B | 2.35B | 1.21B |
| Net Income Continuous Operations | 269.20M | 569.64M | 677.29M | 448.80M | 877.72M | -2.28B |
| Minority Interests | -90.20M | -44.24M | 68.21M | 117.19M | 148.08M | 276.41M |
| Preferred Stock Dividends | 0 | 0 | 0 | 0 | 0 | 0 |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
